161 related articles for article (PubMed ID: 22272097)
21. Evaluation of the oncolytic property of recombinant Newcastle disease virus strain R2B in 4T1 and B16-F10 cells in-vitro.
Ramamurthy N; Pathak DC; D'Silva AL; Batheja R; Mariappan AK; Vakharia VN; Chellappa MM; Dey S
Res Vet Sci; 2021 Oct; 139():159-165. PubMed ID: 34332418
[TBL] [Abstract][Full Text] [Related]
22. [Mechanisms of in vitro anti-tumor effects of a Newcastle disease virus].
Meng S; Bai H; Hu M; Liu W; Wang L; Wu Y; Jiao X; Fan J
Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):512-7. PubMed ID: 19621640
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells.
Kalantari A; Farashi Bonab S; Keyvanfar H; Mortazavi P
Arch Razi Inst; 2020 Oct; 75(3):367-376. PubMed ID: 33025777
[TBL] [Abstract][Full Text] [Related]
24. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.
Fournier P; Bian H; Szeberényi J; Schirrmacher V
Methods Mol Biol; 2012; 797():177-204. PubMed ID: 21948477
[TBL] [Abstract][Full Text] [Related]
25. Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of β-catenin and matrix metalloproteinase-7.
Morla S; Kumar A; Kumar S
Sci Rep; 2019 Jul; 9(1):10882. PubMed ID: 31350432
[TBL] [Abstract][Full Text] [Related]
26. Newcastle disease virus infection promotes Bax redistribution to mitochondria and cell death in HeLa cells.
Molouki A; Hsu YT; Jahanshiri F; Rosli R; Yusoff K
Intervirology; 2010; 53(2):87-94. PubMed ID: 19955813
[TBL] [Abstract][Full Text] [Related]
27. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative effect of newcastle disease virus strain D90 on human lung cancer cell line A549.
Fu F; Zhao M; Yang YJ; Tong GZ; Yang BF; Song C; Li X
Oncol Res; 2011; 19(7):323-33. PubMed ID: 21936402
[TBL] [Abstract][Full Text] [Related]
29. Two avirulent, lentogenic strains of Newcastle disease virus are cytotoxic for some human pancreatic tumor lines in vitro.
Walter RJ; Attar BM; Rafiq A; Delimata M; Tejaswi S
JOP; 2012 Sep; 13(5):502-13. PubMed ID: 22964957
[TBL] [Abstract][Full Text] [Related]
30. Apoptin enhances the oncolytic properties of Newcastle disease virus.
Wu Y; Zhang X; Wang X; Wang L; Hu S; Liu X; Meng S
Intervirology; 2012; 55(4):276-86. PubMed ID: 21865658
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Malaysian velogenic NDV strain AF2240-I genomic sequence: a comparative study.
Murulitharan K; Yusoff K; Omar AR; Molouki A
Virus Genes; 2013 Jun; 46(3):431-40. PubMed ID: 23306943
[TBL] [Abstract][Full Text] [Related]
32. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells.
Mansour M; Palese P; Zamarin D
J Virol; 2011 Jun; 85(12):6015-23. PubMed ID: 21471241
[TBL] [Abstract][Full Text] [Related]
33. Newcastle disease virus LaSota strain kills human pancreatic cancer cells in vitro with high selectivity.
Walter RJ; Attar BM; Rafiq A; Tejaswi S; Delimata M
JOP; 2012 Jan; 13(1):45-53. PubMed ID: 22233946
[TBL] [Abstract][Full Text] [Related]
34. Sequence of the haemagglutinin-neuraminidase gene of the Newcastle disease virus oral vaccine strain V4(UPM).
Yusoff K; Tan WS; Lau CH; Ng BK; Ibrahim AL
Avian Pathol; 1996 Dec; 25(4):837-44. PubMed ID: 18645902
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus.
Reichard KW; Lorence RM; Katubig BB; Peeples ME; Reyes HM
J Pediatr Surg; 1993 Oct; 28(10):1221-5; discussion 1225-6. PubMed ID: 8263678
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
[TBL] [Abstract][Full Text] [Related]
37. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment.
Keshavarz M; Ebrahimzadeh MS; Miri SM; Dianat-Moghadam H; Ghorbanhosseini SS; Mohebbi SR; Keyvani H; Ghaemi A
Virol J; 2020 May; 17(1):64. PubMed ID: 32370750
[TBL] [Abstract][Full Text] [Related]
38. Simulated natural infection of chickens with Australian lentogenic newcastle disease virus and subsequent challenge with virulent virus.
Turner AJ; Hanson RP; Spalatin J
Aust Vet J; 1976 Nov; 52(11):524-8. PubMed ID: 1016154
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo.
Najmuddin SUFS; Amin ZM; Tan SW; Yeap SK; Kalyanasundram J; Ani MAC; Veerakumarasivam A; Chan SC; Chia SL; Yusoff K; Alitheen NB
Cancer Cell Int; 2020; 20():278. PubMed ID: 32612457
[TBL] [Abstract][Full Text] [Related]
40. The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin.
Lazar I; Yaacov B; Shiloach T; Eliahoo E; Kadouri L; Lotem M; Perlman R; Zakay-Rones Z; Panet A; Ben-Yehuda D
J Virol; 2010 Jan; 84(1):639-46. PubMed ID: 19864394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
